Clinical Trial Update: Albuminuria Lowering Effect of Dapagliflozin, Spironolactone and Their Combination in Adult Patients With Alport Syndrome (COMBINE-ALPORT) [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating whether dapagliflozin, spironolactone, or their combination lowers albuminuria in adults with Alport syndrome and related basement memb…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alport Nephropathy
• Alport Syndrome
• Thin Basement Membrane Disease

Drugs mentioned

• Dapagliflozin (dapagliflozin)
• Spironolactone (spironolactone)

Snippet

Sponsor: Stefan Lujinschi | Conditions: Alport Syndrome, Thin Basement Membrane Disease | Phase 4 | Status: ACTIVE_NOT_RECRUITING